Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

2014 Korean Guidelines for Appropriate Utilization of Cardiovascular Magnetic Resonance Imaging: A Joint Report of the Korean Society of Cardiology and the Korean Society of Radiology

  • Yoon, Yeonyee E. (Department of Cardiology, Cardiovascular Center, Seoul National University Bundang Hospital) ;
  • Hong, Yoo Jin (Department of Radiology, Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Hyung-Kwan (Division of Cardiology, Department of Internal Medicine, Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital) ;
  • Kim, Jeong A (Department of Radiology, Ilsan Paik Hospital, Inje University College of Medicine) ;
  • Na, Jin Oh (Cardiovascular Center, Korea University Guro Hospital, Korea University College of Medicine) ;
  • Yang, Dong Hyun (Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Young Jin (Department of Radiology, Severance Hospital, Yonsei University College of Medicine) ;
  • Choi, Eui-Young (Division of Cardiology, Gangnam Severance Hospital, Yonsei University College of Medicine)
  • Received : 2014.09.25
  • Accepted : 2014.10.19
  • Published : 2014.11.30
⟨ Previous Next ⟩

Abstract

Cardiac magnetic resonance (CMR) imaging is now widely used in several fields of cardiovascular disease assessment due to recent technical developments. CMR can give physicians information that cannot be found with other imaging modalities. However, there is no guideline which is suitable for Korean people for the use of CMR. Therefore, we have prepared a Korean guideline for the appropriate utilization of CMR to guide Korean physicians, imaging specialists, medical associates and patients to improve the overall medical system performances. By addressing CMR usage and creating these guidelines we hope to contribute towards the promotion of public health. This guideline is a joint report of the Korean Society of Cardiology and the Korean Society of Radiology.

Keywords

References

  1. Beanlands RS, Chow BJ, Dick A, et al. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary. Can J Cardiol 2007;23:107-19. https://doi.org/10.1016/S0828-282X(07)70730-4
  2. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004;25:1940-65. https://doi.org/10.1016/j.ehj.2004.06.040
  3. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson 2004;6:727-65. https://doi.org/10.1081/JCMR-200038581
  4. ASCI CCT and CMR Guideline Working Group, Kitagawa K, Choi BW, et al. ASCI 2010 appropriateness criteria for cardiac magnetic resonance imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group. Int J Cardiovasc Imaging 2010;26 Suppl 2:173-86.
  5. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardio-vascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006;48:1475-97. https://doi.org/10.1016/j.jacc.2006.07.003
  6. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124:2761-96. https://doi.org/10.1161/CIR.0b013e318223e230
  7. Patel MR, White RD, Abbara S, et al. 2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: a joint report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation Appropriate Use Criteria Task Force. J Am Coll Cardiol 2013; 61:2207-31. https://doi.org/10.1016/j.jacc.2013.02.005
  8. Taylor AJ, Cerqueira M, Hodgson JM, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2010;56:1864-94. https://doi.org/10.1016/j.jacc.2010.07.005
  9. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997;204:373-84. https://doi.org/10.1148/radiology.204.2.9240523
  10. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-5. https://doi.org/10.1161/01.CIR.103.18.2230
  11. Giang TH, Nanz D, Coulden R, et al. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 2004;25:1657-65. https://doi.org/10.1016/j.ehj.2004.06.037
  12. Pilz G, Bernhardt P, Klos M, Ali E, Wild M, Hofling B. Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography. Clin Res Cardiol 2006;95:531-8. https://doi.org/10.1007/s00392-006-0422-7
  13. Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 2012;379:453-60. https://doi.org/10.1016/S0140-6736(11)61335-4
  14. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008;29:480-9. https://doi.org/10.1093/eurheartj/ehm617
  15. Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. singlephoton emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J 2013;34:775-81.
  16. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 2007;50:1343-1353. https://doi.org/10.1016/j.jacc.2007.06.030
  17. Schwitter J, Wacker CM, Wilke N, et al. Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: the secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial). J Cardiovasc Magn Reson 2012;14:61. https://doi.org/10.1186/1532-429X-14-61
  18. Paetsch I, Jahnke C, Ferrari VA, et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J 2006;27:1459-64.
  19. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999;100:1697-702. https://doi.org/10.1161/01.CIR.100.16.1697
  20. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99:763-70. https://doi.org/10.1161/01.CIR.99.6.763
  21. Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 2004;110: 835-42. https://doi.org/10.1161/01.CIR.0000138927.00357.FB
  22. Pennell DJ, Underwood SR, Manzara CC, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992;70:34-40. https://doi.org/10.1016/0002-9149(92)91386-I
  23. Rerkpattanapipat P, Gandhi SK, Darty SN, et al. Feasibility to detect severe coronary artery stenoses with upright treadmill exercise magnetic resonance imaging. Am J Cardiol 2003;92:603-6. https://doi.org/10.1016/S0002-9149(03)00734-3
  24. Schalla S, Klein C, Paetsch I, et al. Real-time MR image acquisition during high-dose dobutamine hydrochloride stress for detecting left ventricular wall-motion abnormalities in patients with coronary arterial disease. Radiology 2002;224:845-51. https://doi.org/10.1148/radiol.2243010945
  25. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009;120:1969-77. https://doi.org/10.1161/CIRCULATIONAHA.109.851352
  26. Wahl A, Paetsch I, Gollesch A, et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J 2004;25:1230-6. https://doi.org/10.1016/j.ehj.2003.11.018
  27. Kuijpers D, Ho KY, van Dijkman PR, Vliegenthart R, Oudkerk M. Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia with the use of myocardial tagging. Circulation 2003; 107:1592-7. https://doi.org/10.1161/01.CIR.0000060544.41744.7C
  28. Korosoglou G, Lehrke S, Wochele A, et al. Strain-encoded CMR for the detection of inducible ischemia during intermediate stress. JACC Cardiovasc Imaging 2010;3:361-71. https://doi.org/10.1016/j.jcmg.2009.11.015
  29. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001; 345:1863-9. https://doi.org/10.1056/NEJMoa010866
  30. Sakuma H, Ichikawa Y, Chino S, Hirano T, Makino K, Takeda K. Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 2006;48:1946-50. https://doi.org/10.1016/j.jacc.2006.07.055
  31. Kato S, Kitagawa K, Ishida N, et al. Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial. J Am Coll Cardiol 2010;56:983-91. https://doi.org/10.1016/j.jacc.2010.01.071
  32. Yang Q, Li K, Liu X, et al. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0-T: a comparative study with X-ray angiography in a single center. J Am Coll Cardiol 2009;54:69-76. https://doi.org/10.1016/j.jacc.2009.03.016
  33. Hamdan A, Asbach P, Wellnhofer E, et al. A prospective study for comparison of MR and CT imaging for detection of coronary artery stenosis. JACC Cardiovasc Imaging 2011;4:50-61. https://doi.org/10.1016/j.jcmg.2010.10.007
  34. Schuetz GM, Zacharopoulou NM, Schlattmann P, Dewey M. Metaanalysis: noninvasive coronary angiography using computed tomography versus magnetic resonance imaging. Ann Intern Med 2010;152: 167-77. https://doi.org/10.7326/0003-4819-152-3-201002020-00008
  35. Nagata M, Kato S, Kitagawa K, et al. Diagnostic accuracy of 1.5-T unenhanced whole-heart coronary MR angiography performed with 32-channel cardiac coils: initial single-center experience. Radiology 2011;259:384-92. https://doi.org/10.1148/radiol.11101323
  36. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM. Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002;106:2328-33. https://doi.org/10.1161/01.CIR.0000036017.46437.02
  37. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007;115:1769-76. https://doi.org/10.1161/CIRCULATIONAHA.106.652016
  38. Gargiulo P, Dellegrottaglie S, Bruzzese D, et al. The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta-analysis. Circ Cardiovasc Imaging 2013;6:574-82.
  39. Lipinski MJ, McVey CM, Berger JS, Kramer CM, Salerno M. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol 2013;62:826-38. https://doi.org/10.1016/j.jacc.2013.03.080
  40. Yoon YE, Kitagawa K, Kato S, et al. Prognostic value of coronary magnetic resonance angiography for prediction of cardiac events in patients with suspected coronary artery disease. J Am Coll Cardiol 2012; 60:2316-22. https://doi.org/10.1016/j.jacc.2012.07.060
  41. Cheitlin MD, De Castro CM, McAllister HA. Sudden death as a complication of anomalous left coronary origin from the anterior sinus of Valsalva, A not-so-minor congenital anomaly. Circulation 1974;50: 780-7. https://doi.org/10.1161/01.CIR.50.4.780
  42. Bunce NH, Lorenz CH, Keegan J, et al. Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography. Radiology 2003;227:201-8. https://doi.org/10.1148/radiol.2271020316
  43. Gharib AM, Ho VB, Rosing DR, et al. Coronary artery anomalies and variants: technical feasibility of assessment with coronary MR angiography at 3 T. Radiology 2008;247:220-7. https://doi.org/10.1148/radiol.2471070274
  44. McConnell MV, Ganz P, Selwyn AP, Li W, Edelman RR, Manning WJ. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation 1995; 92:3158-62. https://doi.org/10.1161/01.CIR.92.11.3158
  45. Taylor AM, Thorne SA, Rubens MB, et al. Coronary artery imaging in grown up congenital heart disease: complementary role of magnetic resonance and x-ray coronary angiography. Circulation 2000;101: 1670-8. https://doi.org/10.1161/01.CIR.101.14.1670
  46. Casolo G, Del Meglio J, Rega L, et al. Detection and assessment of coronary artery anomalies by three-dimensional magnetic resonance coronary angiography. Int J Cardiol 2005;103:317-22. https://doi.org/10.1016/j.ijcard.2004.09.007
  47. Clemente A, Del Borrello M, Greco P, et al. Anomalous origin of the coronary arteries in children: diagnostic role of three-dimensional coronary MR angiography. Clin Imaging 2010;34:337-43. https://doi.org/10.1016/j.clinimag.2009.08.030
  48. Plein S, Greenwood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan MU. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004;44:2173-81. https://doi.org/10.1016/j.jacc.2004.08.056
  49. Kwong RY, Schussheim AE, Rekhraj S, et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003;107:531-7. https://doi.org/10.1161/01.CIR.0000047527.11221.29
  50. Cury RC, Shash K, Nagurney JT, et al. Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation 2008; 118:837-44. https://doi.org/10.1161/CIRCULATIONAHA.107.740597
  51. Miller CD, Hwang W, Case D, et al. Stress CMR imaging observation unit in the emergency department reduces 1-year medical care costs in patients with acute chest pain: a randomized study for comparison with inpatient care. JACC Cardiovasc Imaging 2011;4:862-70. https://doi.org/10.1016/j.jcmg.2011.04.016
  52. Miller CD, Case LD, Little WC, et al. Stress CMR reduces revascularization, hospital readmission, and recurrent cardiac testing in intermediate-risk patients with acute chest pain. JACC Cardiovasc Imaging 2013;6:785-94. https://doi.org/10.1016/j.jcmg.2012.11.022
  53. Kern MJ, Lerman A, Bech JW, et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation 2006;114:1321-41. https://doi.org/10.1161/CIRCULATIONAHA.106.177276
  54. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:e166-286. https://doi.org/10.1161/CIRCULATIONAHA.106.173220
  55. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/ AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:e1-121.
  56. Meijboom WB, Van Mieghem CA, van Pelt N, et al. Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J Am Coll Cardiol 2008;52:636-43. https://doi.org/10.1016/j.jacc.2008.05.024
  57. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24. https://doi.org/10.1056/NEJMoa0807611
  58. Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010;56:177-84. https://doi.org/10.1016/j.jacc.2010.04.012
  59. Hamon M, Fau G, Nee G, Ehtisham J, Morello R, Hamon M. Metaanalysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 2010;12:29. https://doi.org/10.1186/1532-429X-12-29
  60. Rieber J, Huber A, Erhard I, et al. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J 2006;27:1465-71.
  61. Costa MA, Shoemaker S, Futamatsu H, et al. Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol 2007;50:514-22. https://doi.org/10.1016/j.jacc.2007.04.053
  62. Watkins S, McGeoch R, Lyne J, et al. Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation 2009; 120:2207-213. https://doi.org/10.1161/CIRCULATIONAHA.109.872358
  63. Lockie T, Ishida M, Perera D, et al. High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol 2011;57:70-5. https://doi.org/10.1016/j.jacc.2010.09.019
  64. Groothuis JG, Beek AM, Brinckman SL, et al. Combined non-invasive functional and anatomical diagnostic work-up in clinical practice: the magnetic resonance and computed tomography in suspected coronary artery disease (MARCC) study. Eur Heart J 2013;34:1990-8. https://doi.org/10.1093/eurheartj/eht077
  65. Jaarsma C, Leiner T, Bekkers SC, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. J Am Coll Cardiol 2012;59:1719-28. https://doi.org/10.1016/j.jacc.2011.12.040
  66. Bryan AJ, Angelini GD. The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr Opin Cardiol 1994; 9:641-9. https://doi.org/10.1097/00001573-199411000-00002
  67. Barner HB, Standeven JW, Reese J. Twelve-year experience with internal mammary artery for coronary artery bypass. J Thorac Cardiovasc Surg 1985;90:668-75.
  68. Cameron AA, Davis KB, Rogers WJ. Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). Coronary Artery Surgery Study. J Am Coll Cardiol 1995;26:895-9. https://doi.org/10.1016/0735-1097(95)00280-4
  69. Langerak SE, Vliegen HW, de Roos A, et al. Detection of vein graft disease using high-resolution magnetic resonance angiography. Circulation 2002;105:328-33. https://doi.org/10.1161/hc0302.102598
  70. Galjee MA, van Rossum AC, Doesburg T, van Eenige MJ, Visser CA. Value of magnetic resonance imaging in assessing patency and function of coronary artery bypass grafts. An angiographically controlled study. Circulation 1996;93:660-6. https://doi.org/10.1161/01.CIR.93.4.660
  71. Duerinckx AJ, Atkinson D, Hurwitz R. Assessment of coronary artery patency after stent placement using magnetic resonance angiography. J Magn Reson Imaging 1998;8:896-902. https://doi.org/10.1002/jmri.1880080420
  72. Sardanelli F, Zandrino F, Molinari G, Iozzelli A, Balbi M, Barsotti A. MR evaluation of coronary stents with navigator echo and breath-hold cine gradient-echo techniques. Eur Radiol 2002;12:193-200. https://doi.org/10.1007/s003300101017
  73. De Cobelli F, Cappio S, Vanzulli A, Del Maschio A. MRI assessment of coronary stents. Rays 1999;24:140-8.
  74. Duerinckx AJ, Atkinson D, Hurwitz R, Mintorovitch J, Whitney W. Coronary MR angiography after coronary stent placement. AJR Am J Roentgenol 1995;165:662-4. https://doi.org/10.2214/ajr.165.3.7645491
  75. De Cobelli F, Guidetti D, Vanzulli A, Mellone R, Chierchia S, Del Maschio A. [Magnetic resonance angiography of coronary arteries: assessment in patients with coronary stenosis and control after stent positioning]. Radiol Med 1998;95:54-61.
  76. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007;116:1971-96. https://doi.org/10.1161/CIRCULATIONAHA.107.185700
  77. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007;50:e159-241. https://doi.org/10.1016/j.jacc.2007.09.003
  78. Fleisher LA; American College of Cardiology/American Heart Association. Cardiac risk stratification for noncardiac surgery: update from the American College of Cardiology/American Heart Association 2007 guidelines. Cleve Clin J Med 2009;76 Suppl 4:S9-15. https://doi.org/10.3949/ccjm.76.s4.02
  79. Freeman WK, Gibbons RJ. Perioperative cardiovascular assessment of patients undergoing noncardiac surgery. Mayo Clin Proc 2009;84: 79-90. https://doi.org/10.4065/84.1.79
  80. Holt NF. Perioperative cardiac risk reduction. Am Fam Physician 2012;85:239-46.
  81. Nelson CL, Herndon JE, Mark DB, Pryor DB, Califf RM, Hlatky MA. Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index. Am J Cardiol 1991;68: 973-5. https://doi.org/10.1016/0002-9149(91)90423-I
  82. Fathala A, Hassan W. Role of multimodality cardiac imaging in preoperative cardiovascular evaluation before noncardiac surgery. Ann Card Anaesth 2011;14:134-45. https://doi.org/10.4103/0971-9784.81570
  83. Shah DJ, Kim HW, Kim RJ. Evaluation of ischemic heart disease. Heart Fail Clin 2009;5:315-32, v. https://doi.org/10.1016/j.hfc.2009.02.001
  84. Mavrogeni S, Papadopoulos G, Karanasios E, Cokkinos DV. How to image Kawasaki disease: a validation of different imaging techniques. Int J Cardiol 2008;124:27-31. https://doi.org/10.1016/j.ijcard.2007.02.035
  85. Mavrogeni S, Papadopoulos G, Douskou M, et al. Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol 2004;43:649-52. https://doi.org/10.1016/j.jacc.2003.08.052
  86. Mavrogeni S, Papadopoulos G, Douskou M, et al. Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease. J Cardiovasc Magn Reson 2006;8:493-8. https://doi.org/10.1080/10976640600604773
  87. Greil GF, Stuber M, Botnar RM, et al. Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease. Circulation 2002;105:908-11. https://doi.org/10.1161/hc0802.105563
  88. Greil GF, Seeger A, Miller S, et al. Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease. Pediatr Radiol 2007;37:666-73. https://doi.org/10.1007/s00247-007-0498-x
  89. Ferket BS, Genders TS, Colkesen EB, et al. Systematic review of guidelines on imaging of asymptomatic coronary artery disease. J Am Coll Cardiol 2011;57:1591-600. https://doi.org/10.1016/j.jacc.2010.10.055
  90. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-7. https://doi.org/10.1161/hc3501.096798
  91. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53. https://doi.org/10.1056/NEJM200011163432003
  92. Romero J, Kahan J, Kelesidis I, et al. CMR imaging for the evaluation of myocardial stunning after acute myocardial infarction: a metaanalysis of prospective trials. Eur Heart J Cardiovasc Imaging 2013;14: 1080-91. https://doi.org/10.1093/ehjci/jet040
  93. Chan RH, Leung AA, Manning WJ. Prognostic utility of late gadolinium enhancement cardiac magnetic resonance imaging in coronary artery disease: a meta-analysis. J Cardiovasc Magn Reson 2013;15 Suppl 1: O75. https://doi.org/10.1186/1532-429X-15-S1-O75
  94. Romero J, Xue X, Gonzalez W, Garcia MJ. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials. JACC Cardiovasc Imaging 2012;5:494-508. https://doi.org/10.1016/j.jcmg.2012.02.009
  95. Trent RJ, Waiter GD, Hillis GS, McKiddie FI, Redpath TW, Walton S. Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation. Heart 2000;83:40-6. https://doi.org/10.1136/heart.83.1.40
  96. Selvanayagam JB, Kardos A, Francis JM, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004; 110:1535-41. https://doi.org/10.1161/01.CIR.0000142045.22628.74
  97. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9. https://doi.org/10.1016/S0140-6736(03)12389-6
  98. Roes SD, Kaandorp TA, Marsan NA, et al. Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability. Eur J Nucl Med Mol Imaging 2009;36:594-601. https://doi.org/10.1007/s00259-008-1001-0
  99. Crean A, Khan SN, Davies LC, Coulden R, Dutka DP. Assessment of Myocardial Scar; Comparison Between F-FDG PET, CMR and Tc-Sestamibi. Clin Med Cardiol 2009;3:69-76.
  100. Heijenbrok-Kal MH, Fleischmann KE, Hunink MG. Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J 2007;154:415-23. https://doi.org/10.1016/j.ahj.2007.04.061
  101. Eitel I, Desch S, de Waha S, et al. Long-term prognostic value of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. Heart 2011;97:2038-45. https://doi.org/10.1136/heartjnl-2011-300098
  102. Eitel I, Desch S, Fuernau G, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010;55:2470-9. https://doi.org/10.1016/j.jacc.2010.01.049
  103. Selvanayagam JB, Porto I, Channon K, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 2005;111:1027-32. https://doi.org/10.1161/01.CIR.0000156328.28485.AD
  104. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-847. https://doi.org/10.1093/eurheartj/ehs104
  105. Fonseca C. Diagnosis of heart failure in primary care. Heart Fail Rev 2006;11:95-107. https://doi.org/10.1007/s10741-006-9481-0
  106. Kelder JC, Cramer MJ, van Wijngaarden J, et al. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation 2011;124:2865-73. https://doi.org/10.1161/CIRCULATIONAHA.111.019216
  107. Assomull RG, Shakespeare C, Kalra PR, et al. Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation 2011;124:1351-60. https://doi.org/10.1161/CIRCULATIONAHA.110.011346
  108. Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000;21:1387-96. https://doi.org/10.1053/euhj.2000.2011
  109. Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces doserelated improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996;94:2807-16. https://doi.org/10.1161/01.CIR.94.11.2807
  110. Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000;139:596-608.
  111. Doughty RN, Whalley GA, Walsh HA, Gamble GD, Lopez-Sendon J, Sharpe N; CAPRICORN Echo Substudy Investigators. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation 2004;109:201-6. https://doi.org/10.1161/01.CIR.0000108928.25690.94
  112. Alfakih K, Reid S, Jones T, Sivananthan M. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol 2004;14:1813-22.
  113. Holman ER, Buller VG, de Roos A, et al. Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation 1997;95: 924-31. https://doi.org/10.1161/01.CIR.95.4.924
  114. Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004;147: 218-23. https://doi.org/10.1016/j.ahj.2003.10.005
  115. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90:29-34. https://doi.org/10.1016/S0002-9149(02)02381-0
  116. Jenkins C, Moir S, Chan J, Rakhit D, Haluska B, Marwick TH. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J 2009;30:98-106.
  117. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000; 2:271-8. https://doi.org/10.3109/10976640009148691
  118. Kim YJ, Kim RJ. The role of cardiac MR in new-onset heart failure. Curr Cardiol Rep 2011;13:185-93. https://doi.org/10.1007/s11886-011-0179-0
  119. Valle-Munoz A, Estornell-Erill J, Soriano-Navarro CJ, et al. Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure. Eur J Echocardiogr 2009; 10:968-74. https://doi.org/10.1093/ejechocard/jep115
  120. Hamilton-Craig C, Strugnell WE, Raffel OC, Porto I, Walters DL, Slaughter RE. CT angiography with cardiac MRI: non-invasive functional and anatomical assessment for the etiology in newly diagnosed heart failure. Int J Cardiovasc Imaging 2012;28:1111-22. https://doi.org/10.1007/s10554-011-9926-y
  121. Bluemke DA, Kronmal RA, Lima JA, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 2008;52:2148-55. https://doi.org/10.1016/j.jacc.2008.09.014
  122. Olivotto I, Maron MS, Autore C, et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2008;52:559-66. https://doi.org/10.1016/j.jacc.2008.04.047
  123. Follath F, Cleland JG, Klein W, Murphy R. Etiology and response to drug treatment in heart failure. J Am Coll Cardiol 1998;32:1167-72. https://doi.org/10.1016/S0735-1097(98)00400-8
  124. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of nonischaemic cardiomyopathies. Eur Heart J 2005;26:1461-74. https://doi.org/10.1093/eurheartj/ehi258
  125. Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:2156-64. https://doi.org/10.1016/S0735-1097(02)02602-5
  126. Kim KH, Kim HK, Hwang IC, et al. Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2012;14:52. https://doi.org/10.1186/1532-429X-14-52
  127. Moon JC, Sachdev B, Elkington AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24:2151-5. https://doi.org/10.1016/j.ehj.2003.09.017
  128. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-93. https://doi.org/10.1161/01.CIR.0000152819.97857.9D
  129. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8. https://doi.org/10.1161/01.CIR.0000118493.13323.81
  130. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-9. https://doi.org/10.1161/01.CIR.97.18.1802
  131. Klem I, Shah DJ, White RD, et al. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Circ Cardiovasc Imaging 2011;4:610-9.
  132. Klem I, Weinsaft JW, Bahnson TD, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 2012;60:408-20. https://doi.org/10.1016/j.jacc.2012.02.070
  133. Joshi SB, Connelly KA, Jimenez-Juan L, et al. Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation. J Cardiovasc Magn Reson 2012;14:69. https://doi.org/10.1186/1532-429X-14-69
  134. Gao P, Yee R, Gula L, et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 2012;5:448-56. https://doi.org/10.1161/CIRCIMAGING.111.971549
  135. Delgado V, van Bommel RJ, Bertini M, et al. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation 2011;123: 70-8. https://doi.org/10.1161/CIRCULATIONAHA.110.945345
  136. Leyva F, Foley PW. Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy. Heart Fail Rev 2011; 16:251-62. https://doi.org/10.1007/s10741-010-9213-3
  137. Leyva F, Foley PW, Chalil S, et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2011;13:29. https://doi.org/10.1186/1532-429X-13-29
  138. Dickfeld T, Tian J, Ahmad G, et al. MRI-Guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol 2011;4:172-84. https://doi.org/10.1161/CIRCEP.110.958744
  139. Junttila MJ, Fishman JE, Lopera GA, et al. Safety of serial MRI in patients with implantable cardioverter defibrillators. Heart 2011;97: 1852-6. https://doi.org/10.1136/heartjnl-2011-300153
  140. Chessa M, Carrozza M, Butera G, et al. Results and mid-long-term follow-up of stent implantation for native and recurrent coarctation of the aorta. Eur Heart J 2005;26:2728-32. https://doi.org/10.1093/eurheartj/ehi491
  141. Hassan W, Awad M, Fawzy ME, et al. Long-term effects of balloon angioplasty on left ventricular hypertrophy in adolescent and adult patients with native coarctation of the aorta. Up to 18 years follow-up results. Catheter Cardiovasc Interv 2007;70:881-6. https://doi.org/10.1002/ccd.21287
  142. Bogaert J, Kuzo R, Dymarkowski S, et al. Follow-up of patients with previous treatment for coarctation of the thoracic aorta: comparison between contrast-enhanced MR angiography and fast spin-echo MR imaging. Eur Radiol 2000;10:1847-54. https://doi.org/10.1007/s003300000611
  143. Geva T, Greil GF, Marshall AC, Landzberg M, Powell AJ. Gadoliniumenhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with x-ray angiography. Circulation 2002;106: 473-8. https://doi.org/10.1161/01.CIR.0000023624.33478.18
  144. Prasad SK, Soukias N, Hornung T, et al. Role of magnetic resonance angiography in the diagnosis of major aortopulmonary collateral arteries and partial anomalous pulmonary venous drainage. Circulation 2004;109:207-14. https://doi.org/10.1161/01.CIR.0000107842.29467.C5
  145. Fattori R, Bacchi Reggiani L, Pepe C, et al. Magnetic resonance imaging evaluation of aortic elastic properties as early expression of Marfan syndrome. J Cardiovasc Magn Reson 2000;2:251-6. https://doi.org/10.3109/10976640009148688
  146. Baumgartner D, Baumgartner C, Matyas G, et al. Diagnostic power of aortic elastic properties in young patients with Marfan syndrome. J Thorac Cardiovasc Surg 2005;129:730-9. https://doi.org/10.1016/j.jtcvs.2004.07.019
  147. Geva T, Vick GW 3rd, Wendt RE, Rokey R. Role of spin echo and cine magnetic resonance imaging in presurgical planning of heterotaxy syndrome. Comparison with echocardiography and catheterization. Circulation 1994;90:348-56. https://doi.org/10.1161/01.CIR.90.1.348
  148. Salehian O, Schwerzmann M, Merchant N, Webb GD, Siu SC, Therrien J. Assessment of systemic right ventricular function in patients with transposition of the great arteries using the myocardial performance index: comparison with cardiac magnetic resonance imaging. Circulation 2004;110:3229-33. https://doi.org/10.1161/01.CIR.0000147284.54140.73
  149. Warnes CA. Transposition of the great arteries. Circulation 2006;114: 2699-709. https://doi.org/10.1161/CIRCULATIONAHA.105.592352
  150. Rutledge JM, Nihill MR, Fraser CD, Smith OE, McMahon CJ, Bezold LI. Outcome of 121 patients with congenitally corrected transposition of the great arteries. Pediatr Cardiol 2002;23:137-45. https://doi.org/10.1007/s00246-001-0037-8
  151. Didier D, Higgins CB. Identification and localization of ventricular septal defect by gated magnetic resonance imaging. Am J Cardiol 1986; 57:1363-8. https://doi.org/10.1016/0002-9149(86)90219-5
  152. Hundley WG, Li HF, Lange RA, et al. Assessment of left-to-right intracardiac shunting by velocity-encoded, phase-difference magnetic resonance imaging. A comparison with oximetric and indicator dilution techniques. Circulation 1995;91: 2955-60. https://doi.org/10.1161/01.CIR.91.12.2955
  153. Korperich H, Gieseke J, Barth P, et al. Flow volume and shunt quantification in pediatric congenital heart disease by real-time magnetic resonance velocity mapping: a validation study. Circulation 2004;109: 1987-93. https://doi.org/10.1161/01.CIR.0000126494.66859.A2
  154. Beerbaum P, Korperich H, Gieseke J, Barth P, Peuster M, Meyer H. Rapid left-to-right shunt quantification in children by phase-contrast magnetic resonance imaging combined with sensitivity encoding (SENSE). Circulation 2003;108:1355-61. https://doi.org/10.1161/01.CIR.0000087603.97036.C2
  155. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists, Bonow RO, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148. https://doi.org/10.1016/j.jacc.2006.05.021
  156. Rebergen SA, Chin JG, Ottenkamp J, van der Wall EE, de Roos A. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation 1993;88:2257-66. https://doi.org/10.1161/01.CIR.88.5.2257
  157. Apitz C, Webb GD, Redington AN. Tetralogy of Fallot. Lancet 2009; 374:1462-71. https://doi.org/10.1016/S0140-6736(09)60657-7
  158. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005;95:779-82. https://doi.org/10.1016/j.amjcard.2004.11.037
  159. Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007; 116:545-51. https://doi.org/10.1161/CIRCULATIONAHA.106.659664
  160. Babu-Narayan SV, Kilner PJ, Li W, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Circulation 2006;113:405-13. https://doi.org/10.1161/CIRCULATIONAHA.105.548727
  161. Attenhofer Jost CH, Edmister WD, Julsrud PR, et al. Prospective comparison of echocardiography versus cardiac magnetic resonance imaging in patients with Ebstein's anomaly. Int J Cardiovasc Imaging 2012;28:1147-59. https://doi.org/10.1007/s10554-011-9923-1
  162. Yalonetsky S, Tobler D, Greutmann M, et al. Cardiac magnetic resonance imaging and the assessment of ebstein anomaly in adults. Am J Cardiol 2011;107:767-73. https://doi.org/10.1016/j.amjcard.2010.10.058
  163. Lemmer J, Heise G, Rentzsch A, et al. Right ventricular function in grown-up patients after correction of congenital right heart disease. Clin Res Cardiol 2011;100:289-96. https://doi.org/10.1007/s00392-010-0241-8
  164. Grothoff M, Spors B, Abdul-Khaliq H, Gutberlet M. Evaluation of postoperative pulmonary regurgitation after surgical repair of tetralogy of Fallot: comparison between Doppler echocardiography and MR velocity mapping. Pediatr Radiol 2008;38:186-91. https://doi.org/10.1007/s00247-007-0691-y
  165. Roest AA, Helbing WA, Kunz P, et al. Exercise MR imaging in the assessment of pulmonary regurgitation and biventricular function in patients after tetralogy of fallot repair. Radiology 2002;223:204-11. https://doi.org/10.1148/radiol.2231010924
  166. Oosterhof T, Mulder BJ, Vliegen HW, de Roos A. Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot: a review. Am Heart J 2006;151:265-72. https://doi.org/10.1016/j.ahj.2005.03.058
  167. Oosterhof T, Mulder BJ, Vliegen HW, de Roos A. Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract. Radiology 2005;237:868-71. https://doi.org/10.1148/radiol.2373041324
  168. Davlouros PA, Kilner PJ, Hornung TS, et al. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol 2002;40:2044-52. https://doi.org/10.1016/S0735-1097(02)02566-4
  169. Taylor AM, Dymarkowski S, Hamaekers P, et al. MR coronary angiography and late-enhancement myocardial MR in children who underwent arterial switch surgery for transposition of great arteries. Radiology 2005;234:542-7. https://doi.org/10.1148/radiol.2342032059
  170. Garg R, Powell AJ, Sena L, Marshall AC, Geva T. Effects of metallic implants on magnetic resonance imaging evaluation of Fontan palliation. Am J Cardiol 2005;95:688-91. https://doi.org/10.1016/j.amjcard.2004.10.053
  171. Grosse-Wortmann L, Al-Otay A, Yoo SJ. Aortopulmonary collaterals after bidirectional cavopulmonary connection or Fontan completion: quantification with MRI. Circ Cardiovasc Imaging 2009;2:219-25. https://doi.org/10.1161/CIRCIMAGING.108.834192
  172. Fogel MA, Weinberg PM, Chin AJ, Fellows KE, Hoffman EA. Late ventricular geometry and performance changes of functional single ventricle throughout staged Fontan reconstruction assessed by magnetic resonance imaging. J Am Coll Cardiol 1996;28:212-21. https://doi.org/10.1016/0735-1097(96)00111-8
  173. Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation 2009;119:468-78. https://doi.org/10.1161/CIRCULATIONAHA.107.742486
  174. Sondergaard L, Hildebrandt P, Lindvig K, et al. Valve area and cardiac output in aortic stenosis: quantification by magnetic resonance velocity mapping. Am Heart J 1993;126: 156-64.
  175. Caruthers SD, Lin SJ, Brown P, et al. Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation 2003;108:2236-43. https://doi.org/10.1161/01.CIR.0000095268.47282.A1
  176. Djavidani B, Debl K, Lenhart M, et al. Planimetry of mitral valve stenosis by magnetic resonance imaging. J Am Coll Cardiol 2005;45:2048-53. https://doi.org/10.1016/j.jacc.2005.03.036
  177. Honda N, Machida K, Hashimoto M, et al. Aortic regurgitation: quantitation with MR imaging velocity mapping. Radiology 1993;186: 189-94. https://doi.org/10.1148/radiology.186.1.8416562
  178. Ley S, Eichhorn J, Ley-Zaporozhan J, et al. Evaluation of aortic regurgitation in congenital heart disease: value of MR imaging in comparison to echocardiography. Pediatr Radiol 2007;37:426-36. https://doi.org/10.1007/s00247-007-0414-4
  179. Kon MW, Myerson SG, Moat NE, Pennell DJ. Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. J Heart Valve Dis 2004;13:600-7.
  180. Cawley PJ, Hamilton-Craig C, Owens DS, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging 2013;6:48-57. https://doi.org/10.1161/CIRCIMAGING.112.975623
  181. Lee C, Kim YM, Lee CH, et al. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol 2012;60:1005-14. https://doi.org/10.1016/j.jacc.2012.03.077
  182. Sarikouch S, Koerperich H, Dubowy KO, et al. Impact of gender and age on cardiovascular function late after repair of tetralogy of Fallot: percentiles based on cardiac magnetic resonance. Circ Cardiovasc Imaging 2011;4:703-11. https://doi.org/10.1161/CIRCIMAGING.111.963637
  183. Mercer-Rosa L, Yang W, Kutty S, Rychik J, Fogel M, Goldmuntz E. Quantifying pulmonary regurgitation and right ventricular function in surgically repaired tetralogy of Fallot: a comparative analysis of echocardiography and magnetic resonance imaging. Circ Cardiovasc Imaging 2012;5:637-43. https://doi.org/10.1161/CIRCIMAGING.112.972588
  184. Koca B, Oztunc F, Eroglu AG, Gokalp S, Dursun M, Yilmaz R. Evaluation of right ventricular function in patients with tetralogy of Fallot using the myocardial performance index and isovolumic acceleration: a comparison with cardiac magnetic resonance imaging. Cardiol Young 2014;24:422-9. https://doi.org/10.1017/S1047951113000504
  185. Botnar R, Nagel E, Scheidegger MB, Pedersen EM, Hess O, Boesiger P. Assessment of prosthetic aortic valve performance by magnetic resonance velocity imaging. MAGMA 2000;10:18-26. https://doi.org/10.1007/BF02613108
  186. Kozerke S, Hasenkam JM, Nygaard H, Paulsen PK, Pedersen EM, Boesiger P. Heart motion-adapted MR velocity mapping of blood velocity distribution downstream of aortic valve prostheses: initial experience. Radiology 2001;218:548-55. https://doi.org/10.1148/radiology.218.2.r01ja07548
  187. von Knobelsdorff-Brenkenhoff F, Rudolph A, Wassmuth R, et al. Feasibility of cardiovascular magnetic resonance to assess the orifice area of aortic bioprostheses. Circ Cardiovasc Imaging 2009;2:397-404. https://doi.org/10.1161/CIRCIMAGING.108.840967
  188. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010;31:806-14. https://doi.org/10.1093/eurheartj/ehq025
  189. Sen-Chowdhry S, Prasad SK, Syrris P, et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol 2006;48:2132-40. https://doi.org/10.1016/j.jacc.2006.07.045
  190. Keller DI, Osswald S, Bremerich J, et al. Arrhythmogenic right ventricular cardiomyopathy: diagnostic and prognostic value of the cardiac MRI in relation to arrhythmia-free survival. Int J Cardiovasc Imaging 2003;19:537-43; discussion 545-7. https://doi.org/10.1023/B:CAIM.0000004351.40409.ee
  191. Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005;45:98-103. https://doi.org/10.1016/j.jacc.2004.09.053
  192. Hosch W, Kristen AV, Libicher M, et al. Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings. Amyloid 2008;15:196-204. https://doi.org/10.1080/13506120802193233
  193. Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008; 51:1022-30. https://doi.org/10.1016/j.jacc.2007.10.049
  194. Syed IS, Glockner JF, Feng D, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 2010;3:155-64. https://doi.org/10.1016/j.jcmg.2009.09.023
  195. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001;110: 520-7. https://doi.org/10.1016/S0002-9343(01)00677-5
  196. Fallah-Rad N, Walker JR, Wassef A, et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol 2011;57:2263-70. https://doi.org/10.1016/j.jacc.2010.11.063
  197. Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36:493-500. https://doi.org/10.1016/S0735-1097(00)00755-5
  198. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;46:101-5. https://doi.org/10.1016/j.jacc.2005.03.045
  199. Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 2005;111:472-9. https://doi.org/10.1161/01.CIR.0000153801.51470.EB
  200. Haghi D, Fluechter S, Suselbeck T, Kaden JJ, Borggrefe M, Papavassiliu T. Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy). Int J Cardiol 2007;120:205-11. https://doi.org/10.1016/j.ijcard.2006.09.019
  201. Mitchell JH, Hadden TB, Wilson JM, Achari A, Muthupillai R, Flamm SD. Clinical features and usefulness of cardiac magnetic resonance imaging in assessing myocardial viability and prognosis in Takotsubo cardiomyopathy (transient left ventricular apical ballooning syndrome). Am J Cardiol 2007;100:296-301. https://doi.org/10.1016/j.amjcard.2007.02.091
  202. Monney PA, Sekhri N, Burchell T, et al. Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart 2011;97:1312-8. https://doi.org/10.1136/hrt.2010.204818
  203. Jeserich M, Brunner E, Kandolf R, et al. Diagnosis of viral myocarditis by cardiac magnetic resonance and viral genome detection in peripheral blood. Int J Cardiovasc Imaging 2013;29:121-9. https://doi.org/10.1007/s10554-012-0052-2
  204. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 2001;33:655-70. https://doi.org/10.1006/jmcc.2001.1340
  205. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112:855-61. https://doi.org/10.1161/CIRCULATIONAHA.104.507723
  206. Maron MS, Lesser JR, Maron BJ. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance. Am J Cardiol 2010;105:1842-3. https://doi.org/10.1016/j.amjcard.2010.01.367
  207. Moon JC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 2004;90: 645-9. https://doi.org/10.1136/hrt.2003.014969
  208. Maron MS, Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009;54:220-8. https://doi.org/10.1016/j.jacc.2009.05.006
  209. Adabag AS, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51:1369-74. https://doi.org/10.1016/j.jacc.2007.11.071
  210. Minami Y, Kajimoto K, Terajima Y, et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2011;57:2346-55. https://doi.org/10.1016/j.jacc.2011.02.033
  211. Maron MS, Hauser TH, Dubrow E, et al. Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol 2007;100:1293-8. https://doi.org/10.1016/j.amjcard.2007.05.061
  212. Rudolph A, Abdel-Aty H, Bohl S, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 2009;53:284-91. https://doi.org/10.1016/j.jacc.2008.08.064
  213. Moravsky G, Ofek E, Rakowski H, et al. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. JACC Cardiovasc Imaging 2013;6:587-96. https://doi.org/10.1016/j.jcmg.2012.09.018
  214. Flett AS, Hasleton J, Cook C, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 2011;4:150-6. https://doi.org/10.1016/j.jcmg.2010.11.015
  215. Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260-4. https://doi.org/10.1016/j.jacc.2004.03.035
  216. O'Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74. https://doi.org/10.1016/j.jacc.2010.05.010
  217. Bruder O, Wagner A, Jensen CJ, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:875-87. https://doi.org/10.1016/j.jacc.2010.05.007
  218. Ismail TF, Prasad SK, Pennell DJ. Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy. Heart 2012;98:438-42. https://doi.org/10.1136/heartjnl-2011-300814
  219. Maron MS, Appelbaum E, Harrigan CJ, et al. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 2008;1:184-91. https://doi.org/10.1161/CIRCHEARTFAILURE.108.768119
  220. Rubinshtein R, Glockner JF, Ommen SR, et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 2010;3:51-8. https://doi.org/10.1161/CIRCHEARTFAILURE.109.854026
  221. Green JJ, Berger JS, Kramer CM, Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 2012;5:370-7. https://doi.org/10.1016/j.jcmg.2011.11.021
  222. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7. https://doi.org/10.1016/S0735-1097(03)00189-X
  223. Fluechter S, Kuschyk J, Wolpert C, et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2010;12:30. https://doi.org/10.1186/1532-429X-12-30
  224. To AC, Dhillon A, Desai MY. Cardiac magnetic resonance in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 2011;4:1123-37. https://doi.org/10.1016/j.jcmg.2011.06.022
  225. Germans T, Wilde AA, Dijkmans PA, et al. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 2006;48:2518-23. https://doi.org/10.1016/j.jacc.2006.08.036
  226. Maron MS, Rowin EJ, Lin D, et al. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 2012;5:441-7.
  227. Maron MS, Olivotto I, Harrigan C, et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation 2011;124:40-7. https://doi.org/10.1161/CIRCULATIONAHA.110.985812
  228. Rowin EJ, Maron MS, Lesser JR, Maron BJ. CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 2012;5:119-22.
  229. Weinsaft JW, Kim HW, Crowley AL, et al. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC Cardiovasc Imaging 2011;4: 702-12. https://doi.org/10.1016/j.jcmg.2011.03.017
  230. Mollet NR, Dymarkowski S, Volders W, et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 2002;106:2873-6. https://doi.org/10.1161/01.CIR.0000044389.51236.91
  231. Hong YJ, Hur J, Kim YJ, et al. The usefulness of delayed contrast-enhanced cardiovascular magnetic resonance imaging in differentiating cardiac tumors from thrombi in stroke patients. Int J Cardiovasc Imaging 2011;27 Suppl 1:89-95.
  232. Weinsaft JW, Kim RJ, Ross M, et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovasc Imaging 2009; 2:969-79. https://doi.org/10.1016/j.jcmg.2009.03.017
  233. Motwani M, Kidambi A, Herzog BA, Uddin A, Greenwood JP, Plein S. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology 2013;268:26-43. https://doi.org/10.1148/radiol.13121239
  234. Fieno DS, Saouaf R, Thomson LE, Abidov A, Friedman JD, Berman DS. Cardiovascular magnetic resonance of primary tumors of the heart: a review. J Cardiovasc Magn Reson 2006;8:839-53. https://doi.org/10.1080/10976640600777975
  235. Gulati G, Sharma S, Kothari SS, Juneja R, Saxena A, Talwar KK. Comparison of echo and MRI in the imaging evaluation of intracardiac masses. Cardiovasc Intervent Radiol 2004;27:459-69.
  236. Francone M, Dymarkowski S, Kalantzi M, Rademakers FE, Bogaert J. Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy. Eur Radiol 2006;16:944-51. https://doi.org/10.1007/s00330-005-0009-0
  237. Mastouri R, Sawada SG, Mahenthiran J. Noninvasive imaging techniques of constrictive pericarditis. Expert Rev Cardiovasc Ther 2010;8: 1335-47. https://doi.org/10.1586/erc.10.77
  238. Zurick AO, Bolen MA, Kwon DH, et al. Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. JACC Cardiovasc Imaging 2011;4:1180-91. https://doi.org/10.1016/j.jcmg.2011.08.011
  239. Axel L. Assessment of pericardial disease by magnetic resonance and computed tomography. J Magn Reson Imaging 2004;19:816-26. https://doi.org/10.1002/jmri.20076
  240. Shiga T, Wajima Z, Apfel CC, Inoue T, Ohe Y. Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systematic review and meta-analysis. Arch Intern Med 2006;166: 1350-6. https://doi.org/10.1001/archinte.166.13.1350
  241. Lacomis JM, Pealer K, Fuhrman CR, Barley D, Wigginton W, Schwartzman D. Direct comparison of computed tomography and magnetic resonance imaging for characterization of posterior left atrial morphology. J Interv Card Electrophysiol 2006;16:7-13. https://doi.org/10.1007/s10840-006-9016-6
  242. Kato R, Lickfett L, Meininger G, et al. Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation: lessons learned by use of magnetic resonance imaging. Circulation 2003;107:2004-10. https://doi.org/10.1161/01.CIR.0000061951.81767.4E
  243. Mansour M, Refaat M, Heist EK, et al. Three-dimensional anatomy of the left atrium by magnetic resonance angiography: implications for catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2006;17:719-23. https://doi.org/10.1111/j.1540-8167.2006.00491.x
  244. Durongpisitkul K, Tang NL, Soongswang J, Laohaprasitiporn D, Nana A, Kangkagate C. Cardiac magnetic resonance imaging of atrial septal defect for transcatheter closure. J Med Assoc Thai 2002;85 Suppl 2: S658-66.
  245. Weber C, Weber M, Ekinci O, et al. Atrial septal defects type II: noninvasive evaluation of patients before implantation of an Amplatzer Septal Occluder and on follow-up by magnetic resonance imaging compared with TEE and invasive measurement. Eur Radiol 2008;18: 2406-13. https://doi.org/10.1007/s00330-008-1033-7
  246. Thomson LE, Crowley AL, Heitner JF, et al. Direct en face imaging of secundum atrial septal defects by velocity-encoded cardiovascular magnetic resonance in patients evaluated for possible transcatheter closure. Circ Cardiovasc Imaging 2008;1:31-40. https://doi.org/10.1161/CIRCIMAGING.108.769786
  247. La Manna A, Sanfilippo A, Capodanno D, et al. Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study. J Cardiovasc Magn Reson 2011;13:82. https://doi.org/10.1186/1532-429X-13-82

Cited by

  1. Guidelines for Cardiovascular Magnetic Resonance Imaging from the Korean Society of Cardiovascular Imaging-Part 2: Interpretation of Cine, Flow, and Angiography Data vol.3, pp.4, 2019, https://doi.org/10.22468/cvia.2019.00115
  2. Guidelines for Cardiovascular Magnetic Resonance Imaging from the Korean Society of Cardiovascular Imaging-Part 2: Interpretation of Cine, Flow, and Angiography Data vol.20, pp.11, 2019, https://doi.org/10.3348/kjr.2019.0407
  3. Guidelines for Cardiovascular Magnetic Resonance Imaging from the Korean Society of Cardiovascular Imaging (KOSCI) - Part 2: Interpretation of Cine, Flow, and Angiography Data vol.23, pp.4, 2014, https://doi.org/10.13104/imri.2019.23.4.316